Source: Pharmacy Times articles
Despite being an effective treatment option, intravenous immunoglobulin (IVIG) can cause transient adverse events in pediatrics with primary immunodeficiency, including headache and fever.
Read More
by MM360 Staff | May 13, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Despite being an effective treatment option, intravenous immunoglobulin (IVIG) can cause transient adverse events in pediatrics with primary immunodeficiency, including headache and fever.
Read More